Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wallis

Showing results (431-440 of 476) with videos related to

Pageof 48
Sort By:
Antimicrobial Agents and Chemotherapy|October 23, 2019
Meropenem-Tobramycin Combination Regimens Combat Carbapenem-Resistant Pseudomonas aeruginosa in the Hollow-Fiber Infection Model Simulating Augmented Renal Clearance in Critically Ill PatientsRajbharan Yadav, Phillip J Bergen, Kate E Rogers, et al.
Clinical Pharmacology and Therapeutics|February 7, 2021
Evaluation of Meropenem-Ciprofloxacin Combination Dosage Regimens for the Pharmacokinetics of Critically Ill Patients With Augmented Renal ClearanceAkosua A Agyeman, Kate E Rogers, Jessica R Tait, et al.
Intensive Care Medicine|March 31, 2015
Erratum to: Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patientsJan J De Waele, J Lipman, M Akova, et al.
Intensive Care Medicine|July 24, 2014
Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patientsJan J De Waele, J Lipman, M Akova, et al.
British Journal of Anaesthesia|January 23, 2025
A pharmacokinetic/pharmacodynamic analysis of intravenous tranexamic acid in adult patients undergoing elective total hip arthroplasty (ORACLE)Usha Gurunathan, Robert L Medcalf, Lily Chiang, et al.
Antimicrobial Agents and Chemotherapy|December 18, 2024
Population pharmacokinetics of caspofungin in critically ill patients receiving extracorporeal membrane oxygenation-an ASAP ECMO studyMohd H Abdul-Aziz, Arne Diehl, Xin Liu, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2020
Pharmacodynamic Evaluation of Plasma and Epithelial Lining Fluid Exposures of Amikacin against Pseudomonas aeruginosa in a Dynamic <i>In Vitro</i> Hollow-Fiber Infection ModelAaron J Heffernan, Fekade B Sime, Derek S Sarovich, et al.
Genome Biology|November 21, 2007
The multiple sex chromosomes of platypus and echidna are not completely identical and several share homology with the avian ZWillem Rens, Patricia C M O'Brien, Frank Grützner, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|June 16, 2012
Development of simulated and ovine models of extracorporeal life support to improve understanding of circuit-host interactionsKiran Shekar, Yoke L Fung, Sara Diab, et al.
Critical Care (London, England)|June 3, 2014
Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI studyStijn Blot, Despoina Koulenti, Murat Akova, et al.
Pageof 48

Showing results (431-440 of 476) with videos related to

Sort By:
Pageof 48
Antimicrobial Agents and Chemotherapy|October 23, 2019
Meropenem-Tobramycin Combination Regimens Combat Carbapenem-Resistant Pseudomonas aeruginosa in the Hollow-Fiber Infection Model Simulating Augmented Renal Clearance in Critically Ill PatientsRajbharan Yadav, Phillip J Bergen, Kate E Rogers, et al.
Clinical Pharmacology and Therapeutics|February 7, 2021
Evaluation of Meropenem-Ciprofloxacin Combination Dosage Regimens for the Pharmacokinetics of Critically Ill Patients With Augmented Renal ClearanceAkosua A Agyeman, Kate E Rogers, Jessica R Tait, et al.
Intensive Care Medicine|March 31, 2015
Erratum to: Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patientsJan J De Waele, J Lipman, M Akova, et al.
Intensive Care Medicine|July 24, 2014
Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patientsJan J De Waele, J Lipman, M Akova, et al.
British Journal of Anaesthesia|January 23, 2025
A pharmacokinetic/pharmacodynamic analysis of intravenous tranexamic acid in adult patients undergoing elective total hip arthroplasty (ORACLE)Usha Gurunathan, Robert L Medcalf, Lily Chiang, et al.
Antimicrobial Agents and Chemotherapy|December 18, 2024
Population pharmacokinetics of caspofungin in critically ill patients receiving extracorporeal membrane oxygenation-an ASAP ECMO studyMohd H Abdul-Aziz, Arne Diehl, Xin Liu, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2020
Pharmacodynamic Evaluation of Plasma and Epithelial Lining Fluid Exposures of Amikacin against Pseudomonas aeruginosa in a Dynamic <i>In Vitro</i> Hollow-Fiber Infection ModelAaron J Heffernan, Fekade B Sime, Derek S Sarovich, et al.
Genome Biology|November 21, 2007
The multiple sex chromosomes of platypus and echidna are not completely identical and several share homology with the avian ZWillem Rens, Patricia C M O'Brien, Frank Grützner, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|June 16, 2012
Development of simulated and ovine models of extracorporeal life support to improve understanding of circuit-host interactionsKiran Shekar, Yoke L Fung, Sara Diab, et al.
Critical Care (London, England)|June 3, 2014
Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI studyStijn Blot, Despoina Koulenti, Murat Akova, et al.
Pageof 48